Related Experiment Video

Updated: May 20, 2026

Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using χCRAC
09:15

Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using χCRAC

Published on: May 9, 2020

Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis

Patricia Rada1, Ana I Rojo, Nathalie Evrard-Todeschi

  • 1Departamento de Bioquímica e Instituto de Investigaciones Biomédicas Alberto Sols UAM-CSIC, Centro de Investigación en Red Sobre Enfermedades Neurodegenerativas, Madrid, Spain.

Molecular and Cellular Biology
|July 4, 2012
PubMed

Insights

The study reveals how glycogen synthase kinase 3 beta (GSK-3β) regulates Nrf2 stability via phosphorylation, impacting the phase 2 response. Inhibiting GSK-3β boosts Nrf2 levels and antioxidant defenses in vivo.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cellular Signaling

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of the phase 2 response, crucial for maintaining redox homeostasis.
  • Nrf2 protein stability is modulated by E3 ubiquitin ligase adaptors, including Keap1 and the recently identified β-TrCP.

Purpose of the Study:

  • To elucidate the structural and functional mechanisms by which glycogen synthase kinase 3 beta (GSK-3β) regulates Nrf2 stability through its interaction with β-TrCP.
  • To investigate the physiological consequences of modulating the GSK-3β/β-TrCP axis on Nrf2 activity and the phase 2 response.

Main Methods:

  • Two-dimensional (2D) gel electrophoresis and site-directed mutagenesis to identify Nrf2 phosphorylation sites.
  • Nuclear magnetic resonance (NMR) studies to define the interaction interface between phosphorylated Nrf2 and β-TrCP.
  • In vivo studies using GSK-3β inhibitor administration and gene knockout models.

Main Results:

  • Identified two critical serine residues in Nrf2 phosphorylated by GSK-3β, mediating docking to β-TrCP via electrostatic and hydrophobic interactions.
  • Defined specific arginine residues on β-TrCP essential for Nrf2 binding.
  • Demonstrated that GSK-3β inhibition or absence increases Nrf2 and phase 2 gene product levels in liver and hippocampus, enhancing antioxidant capacity.

Conclusions:

  • Established the structural basis for Nrf2 interaction with the GSK-3β/β-TrCP signaling axis.
  • Highlighted the functional significance of this axis in controlling Nrf2-mediated redox homeostasis and the phase 2 response.
  • Provided evidence for therapeutic potential of targeting GSK-3β to modulate Nrf2 activity in physiological and pathological contexts.

More Related Videos

Oligopeptide Competition Assay for Phosphorylation Site Determination09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...